The company isn't content with just one area of focus; it's actively expanding into new verticals like injectables, peptides, and biosimilars, while simultaneously broadening its geographical ...

Addressing the calculation of patent term extensions (PTEs) under the Hatch-Waxman Act, the US Court of Appeals for the Federal Circuit affirmed ...

Shares of Aurobindo Pharmaceuticals dropped 2% to a day's low of Rs 1,132.75, while Ipca Laboratories fell 2.7% to Rs ...

On March 13, 2025, the Federal Circuit issued a decision in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc., No. 23-2254 (Fed. Cir. 2025) ...

ET Intelligence Group: The stock of Aurobindo Pharma has lost 13% in 2025 so far, underperforming the 10% drop in the BSE ...

Telangana: Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has received an Establishment ...

With markets staging a strong recovery so far in March after enduring five consecutive months of decline, analysts at JM ...

U.S. President Trump imposes 25% tariff on auto imports, spotlight on pharma imports, Indian industry at risk.

Hyderabad: Nearly a year and a half after its subsidiary, Auro Vaccines Pvt Ltd, inked a licensing pact with Hilleman ...

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.